Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05126953 · ClinicalTrials.gov registry record · NA
2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05126953 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants.
The verdict
NCT05126953, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.
Interventions
- DEVICE samfilcon A Lenses with EPG01 Packaging Solution
- DEVICE Commercially Available B+L Ultra Lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2021-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05126953
The ClinicalTrials.gov registry entry for NCT05126953 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which samfilcon A Lenses with EPG01 Packaging Solution is the first listed.
NCT05126953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05126953 about?
NCT05126953 is a clinical study titled "2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses". The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.
What is the current status of trial NCT05126953?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-21. Estimated completion is 2021-09-23.
What interventions are being tested in trial NCT05126953?
The interventions under investigation include: samfilcon A Lenses with EPG01 Packaging Solution (DEVICE), Commercially Available B+L Ultra Lenses (DEVICE).
Who is sponsoring clinical trial NCT05126953?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.